SNOA - Sonoma stock soars 21% on EPA approval of Nanocyn as hospital-grade disinfectant
Sonoma Pharmaceuticals (NASDAQ:SNOA) and its partner MicroSafe Group DMCC said they received U.S. Environmental Protection Agency (EPA) approval for Nanocyn as a hospital-grade disinfectant in the U.S. Nanocyn, which is manufactured by Sonoma using its patented Microcyn technology, is a ready to use hard-surface disinfectant. The companies said that Nanocyn is currently sold by MicroSafe in Europe, the Middle East, West Africa and Australia. The companies noted that Nanocyn has been proven to kill a variety of bacteria, such as Staphylococcus aureus and Pseudomonas aeruginosa, and has a 30 second kill time for many viruses, including norovirus, on hard non-porous surfaces. SNOA +20.68% to $3.21 premarket May 3
For further details see:
Sonoma stock soars 21% on EPA approval of Nanocyn as hospital-grade disinfectant